Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix

Implantable Clip Improves Heart Function and Quality of Life

By HospiMedica International staff writers
Posted on 12 Nov 2013
Print article
Image: The MitraClip clip delivery system (Photo courtesy of Abbott Vascular).
Image: The MitraClip clip delivery system (Photo courtesy of Abbott Vascular).
A new implantable clip helps patients suffering from degenerative mitral regurgitation who have a prohibitively high risk of complications from open-heart mitral valve surgery.

The MitraClip sytem includes three components: an 8 mm (24F) steerable guide catheter for percutaneous venous access; a clip delivery system that includes the implant attached to a highly maneuverable delivery catheter, with all controls at the proximal end; and the MitraClip device itself, a 4 mm-wide cobalt-chromium clip that is coated in polyester to promote tissue growth. The clip clamps to the mitral valve's two edges, holding them together. Since the heart beats normally during the procedure, the procedure does not require a heart-lung bypass machine.

Among the benefits of the device are a positive safety profile, reduction in mitral regurgitation, favorable left ventricular remodeling, improvement in patient symptoms, and reduction in hospitalizations for heart failure (HF). The clip can be used is magnetic resonance imaging (MRI) systems with a magnet strength of up to 3 Tesla. The MitraClip sytem is a product of Abbott Vascular (Abbott Park, NJ, USA), and has been approved by the US Food and Drug Administration (FDA).

“FDA approval of MitraClip marks an important milestone for Abbott as we continue to bring forward innovative therapies to help patients live better lives,” said Chuck Foltz, senior vice president of Abbott Vascular. “We look forward to making this technology available to specialized centers in the US with multidisciplinary teams experienced in the management of patients with heart valve disease, a model that facilitates dialogue across physician specialties and provides patients with the best treatment outcomes."

“As cardiac surgeons, we see patients with severe mitral regurgitation who we can technically operate on but who are just too frail or sick to survive mitral valve surgery with a reasonable risk and quality of life,” said Michael Mack, MD, director of cardiovascular research and surgery at Baylor Health Care System (Dallas, TX, USA). “With the MitraClip system, heart teams now have a catheter-based, less-invasive treatment option that can help patients who cannot withstand surgery regain their quality of life.”

Related Links:

Abbott Vascular



Print article
Radcal
Fluke Biomedical

Channels

Women's Health

view channel
Image: The vaginal probe device, designed for cervical cancer screening (Photo courtesy of Biop Medical).

Optical Scanner Advances Cervical Cancer Screening

A new technology optimizes the cervical cancer (CC) screening process into a single, three-minute painless optical scan. The Biop device is a probe inserted into the vaginal canal that optically identifies... Read more

Business

view channel

Otsuka and IBM Partner in Digital Health Venture

IBM (Armonk, NY, USA) and Otsuka Pharma (Tokyo, Japan) have formed a joint venture to market software that will integrate and analyze psychiatric patient data in Japan. The joint venture will be named Otsuka Digital Health, with the pharma company taking an 85% stake and IBM Japan holding the remaining 15%.... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.